MONTANI, MARIA NADIA
 Distribuzione geografica
Continente #
NA - Nord America 1.966
AS - Asia 1.597
EU - Europa 1.401
SA - Sud America 128
AF - Africa 22
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.122
Nazione #
US - Stati Uniti d'America 1.940
CN - Cina 995
SG - Singapore 323
IE - Irlanda 317
UA - Ucraina 243
FI - Finlandia 187
DE - Germania 155
RU - Federazione Russa 144
HK - Hong Kong 139
BR - Brasile 100
IT - Italia 100
GB - Regno Unito 88
SE - Svezia 73
VN - Vietnam 39
PL - Polonia 25
FR - Francia 24
IN - India 22
IR - Iran 16
BE - Belgio 15
AR - Argentina 13
CA - Canada 13
BD - Bangladesh 12
JP - Giappone 11
MX - Messico 9
MU - Mauritius 8
ID - Indonesia 7
IQ - Iraq 7
NL - Olanda 7
ZA - Sudafrica 7
EC - Ecuador 5
AU - Australia 4
CH - Svizzera 4
LT - Lituania 4
PK - Pakistan 4
TR - Turchia 4
CZ - Repubblica Ceca 3
GR - Grecia 3
RO - Romania 3
VE - Venezuela 3
AZ - Azerbaigian 2
CL - Cile 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
KE - Kenya 2
NZ - Nuova Zelanda 2
OM - Oman 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CG - Congo 1
CI - Costa d'Avorio 1
CO - Colombia 1
DM - Dominica 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
SM - San Marino 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.122
Città #
Chandler 322
Dublin 315
Jacksonville 298
Nanjing 232
Beijing 164
Singapore 158
Ashburn 139
Hong Kong 139
Dallas 130
Boardman 113
Nanchang 86
Hebei 73
Changsha 72
Ann Arbor 64
Lawrence 64
Princeton 64
Shenyang 59
Jiaxing 58
Wilmington 53
Helsinki 52
Los Angeles 47
Medford 45
Tianjin 43
Hangzhou 30
Moscow 24
Buffalo 23
Munich 23
Woodbridge 22
Des Moines 19
New York 17
Brussels 15
Seattle 15
Shanghai 15
Verona 15
Radomsko 14
Kunming 12
Milan 12
Ho Chi Minh City 11
Redondo Beach 11
Tokyo 11
Warsaw 11
Chicago 10
Hanoi 10
Jinan 10
Turku 10
Norwalk 9
Poplar 9
Denver 8
Fairfield 8
Orem 8
San Francisco 8
Brooklyn 7
Chennai 7
Leawood 7
Manchester 7
São Paulo 7
Zanjan 7
Zhengzhou 7
Auburn Hills 6
Ningbo 6
Stockholm 6
Biên Hòa 5
Boston 5
Council Bluffs 5
Falkenstein 5
Guangzhou 5
Mumbai 5
Phoenix 5
Rome 5
Taizhou 5
Atlanta 4
Dhaka 4
Fuzhou 4
Houston 4
Johannesburg 4
Lanzhou 4
London 4
Mexico City 4
Santa Clara 4
Toronto 4
Washington 4
Ardabil 3
Baghdad 3
Bern 3
Ceska 3
Changchun 3
Charlotte 3
Haiphong 3
Hải Dương 3
Jakarta 3
Las Vegas 3
New Delhi 3
Quito 3
Rio de Janeiro 3
Shaoxing 3
Sydney 3
The Dalles 3
Amsterdam 2
Baku 2
Belo Horizonte 2
Totale 3.390
Nome #
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 130
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 128
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 123
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 111
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 110
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 109
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 108
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 108
Abnormalities in thrombin-antithrombin pathway in AL amyloidosis. 106
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 105
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 103
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 103
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 102
Clotting alterations in primary systemic amyloidosis. 98
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 96
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 94
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 93
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 89
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 89
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 88
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 88
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 85
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 84
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 84
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 82
Performance in sports of children and adolescents with hereditary bleeding disorders 82
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 81
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 79
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 79
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 78
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 78
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 78
Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects. 77
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 77
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 76
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 75
Clotting alterations in primary systemic amyloidosis 75
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 75
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 73
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 72
Platelet function after in vivo and in vitro treatment with thrombolytic agents 72
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 71
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 70
Bleeding tendency in type I neurofibromatosis is related to von Willebrand factor abnormalities 70
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 69
Bleeding tendency of unknown origin and protein Z levels. 69
Purpura Fulminans As Clinical Manifestation of Atypical Sle With Antiphospholipid Antibodies - A Case-report 68
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 68
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 67
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 64
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 63
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 63
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 62
Homocysteine and liver steatosis in HCV infected haemophiliacs 62
Risk of venous thrombosis (VT) and hormonal replacement therapy (HRT) in Turner sindrome 61
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 61
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 60
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 57
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 54
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 53
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 52
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 51
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 48
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 46
Totale 5.152
Categoria #
all - tutte 21.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021272 0 0 0 0 0 59 6 63 9 65 57 13
2021/2022311 10 0 7 6 2 3 14 13 24 13 39 180
2022/2023958 110 65 3 86 110 115 0 48 367 12 29 13
2023/2024253 44 36 14 25 40 54 1 19 4 3 11 2
2024/2025733 11 70 15 24 18 32 12 51 177 14 96 213
2025/2026973 159 146 178 206 223 61 0 0 0 0 0 0
Totale 5.152